BRIACELL THERAP Capex/Depreciation

Capex/Depreciation of BCTX for past 10 years: annual, quarterly and twelve month trailing (TTM) including Capex/Depreciation growth rates and interactive chart.


Highlights and Quick Summary

  • Capex/Depreciation for the quarter ending October 31, 2022 was 0.0 (a NaN% decrease compared to previous quarter)
  • Year-over-year quarterly Capex/Depreciation decreased by NaN%
  • Annual Capex/Depreciation for 2022 was 0.0 (a NaN% decrease from previous year)
  • Annual Capex/Depreciation for 2021 was 0.0 (a NaN% decrease from previous year)
  • Annual Capex/Depreciation for 2020 was 0.0 (a NaN% decrease from previous year)
  • Twelve month Capex/Depreciation ending October 31, 2022 was 0.0 (a NaN% decrease compared to previous quarter)
  • Twelve month trailing Capex/Depreciation decreased by NaN% year-over-year
Trailing Capex/Depreciation for the last four month:
31 Oct '22 31 Jul '22 30 Apr '22 31 Jan '22
0.0 0.0 0.0 0.0
Visit stockrow.com/BCTX for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Capex/Depreciation of BRIACELL THERAP

Most recent Capex/Depreciationof BCTX including historical data for past 10 years.

Interactive Chart of Capex/Depreciation of BRIACELL THERAP

BRIACELL THERAP Capex/Depreciation for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 0.0 0.0 0.0 0.0 0.0
2021 0.0 0.0 0.0 0.0 0.0
2020 0.0 0.0 0.0 0.0 0.0
2019 0.0 0.0 0.0 0.0 0.0
2018 0.0 0.0 0.0 0.0 0.0
2017 0.0 0.0 0.0 0.0 0.0
2016 0.0 0.0 0.0 0.0 0.0
2015 0.0 0.0 -9.0 0.0 -3.8
2014 0.0 133.0 430.0 -1864.0 -86.64
2013 -556.0 1739.0 25.0 1386.0 -191.25
2012 -3908.0 -2757.5 -273.5 -1330.78 -1396.59

Business Profile of BRIACELL THERAP

Sector: Healthcare
Industry: Biotechnology